You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PROMETHAZINE VC PLAIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Promethazine Vc Plain, and what generic alternatives are available?

Promethazine Vc Plain is a drug marketed by Cenci and Xttrium Labs Inc and is included in two NDAs.

The generic ingredient in PROMETHAZINE VC PLAIN is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROMETHAZINE VC PLAIN?
  • What are the global sales for PROMETHAZINE VC PLAIN?
  • What is Average Wholesale Price for PROMETHAZINE VC PLAIN?
Drug patent expirations by year for PROMETHAZINE VC PLAIN
Drug Prices for PROMETHAZINE VC PLAIN

See drug prices for PROMETHAZINE VC PLAIN

Recent Clinical Trials for PROMETHAZINE VC PLAIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Trauma CenterN/A
Oman Medical Speciality BoardPhase 3
Tanta UniversityN/A

See all PROMETHAZINE VC PLAIN clinical trials

US Patents and Regulatory Information for PROMETHAZINE VC PLAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cenci PROMETHAZINE VC PLAIN phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088815-001 Nov 22, 1985 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Xttrium Labs Inc PROMETHAZINE VC PLAIN phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088897-001 Jan 4, 1985 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

PROMETHAZINE VC PLAIN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Promethazine VC Plain

Introduction

Promethazine VC Plain, a combination medication of phenylephrine and promethazine, is widely used to treat various cold and allergy symptoms. Understanding the market dynamics and financial trajectory of this drug is crucial for pharmaceutical companies, investors, and healthcare professionals.

Market Overview

Promethazine VC Plain falls under the category of upper respiratory combinations, which is a significant segment in the pharmaceutical market. This segment is driven by the high prevalence of allergic reactions, colds, and respiratory issues globally.

Demand and Supply

The demand for Promethazine VC Plain is steady due to its effectiveness in treating common cold and allergy symptoms. However, the supply chain has been affected by the discontinuation of the brand name "Promethazine VC Plain" in the U.S., although generic versions are still available and approved by the FDA[4].

Pharmacological Profile

Mechanism of Action

Promethazine, an antihistamine, reduces the effects of histamine in the body, alleviating symptoms such as sneezing, runny nose, and watery eyes. Phenylephrine, a decongestant, shrinks blood vessels in the nasal passages, reducing nasal congestion[4].

Indications and Uses

Promethazine VC Plain is indicated for treating sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms. Its versatility in treating multiple symptoms makes it a popular choice among consumers[4].

Market Segmentation

Patient Demographics

The primary users of Promethazine VC Plain include individuals suffering from seasonal allergies, common colds, and other respiratory issues. This demographic is broad and includes people of all ages, although usage may be more prevalent among children and adults with chronic allergies.

Geographic Distribution

The market for Promethazine VC Plain is global, with significant demand in regions with high allergy prevalence. However, regulatory approvals and availability can vary by country.

Financial Performance

Pricing

The pricing of Promethazine VC Plain can vary depending on the region, pharmacy, and whether it is a brand name or generic version. For instance, the cost of Promethazine VC Plain can range from a few dollars to over $10 per unit, depending on the dosage and formulation[2].

Revenue Trends

The revenue generated by Promethazine VC Plain is substantial due to its widespread use. However, the discontinuation of the brand name and the availability of generic alternatives have likely impacted the revenue trajectory. Generic versions typically offer lower pricing, which can reduce overall revenue but maintain market share through higher volume sales.

Competitive Landscape

Market Competitors

The market for upper respiratory combinations is competitive, with several other medications available, such as diphenhydramine and loratadine combinations. However, Promethazine VC Plain remains a preferred choice due to its efficacy and the combination of a decongestant and antihistamine[4].

Generic Competition

The availability of generic versions of Promethazine VC Plain has increased competition, driving prices down and potentially reducing the revenue of original brand name manufacturers. Generic competition is a significant factor in the financial trajectory of this drug.

Regulatory Environment

FDA Approvals

Promethazine VC Plain, including its generic versions, must comply with FDA regulations. The FDA's approval process ensures the safety and efficacy of the medication, which is crucial for maintaining market trust and compliance[4].

Safety and Side Effects

The medication comes with several potential side effects, including dizziness, drowsiness, and dry mouth. Serious side effects such as seizures, jaundice, and severe nervous system reactions can also occur. These factors are closely monitored by regulatory bodies and can impact market dynamics if safety concerns arise[4].

Market Trends and Outlook

Growing Demand for Over-the-Counter Medications

There is a growing trend towards self-medication and the use of over-the-counter (OTC) medications. Promethazine VC Plain, being an OTC medication, benefits from this trend, which is expected to continue driving demand.

Impact of Seasonal Allergies

Seasonal allergies significantly influence the demand for Promethazine VC Plain. Regions with high pollen counts and allergy prevalence see increased sales during specific times of the year.

Financial Projections

Revenue Projections

Despite the discontinuation of the brand name, the revenue from Promethazine VC Plain is expected to remain stable due to the continued demand for generic versions. The market is projected to grow moderately, driven by the increasing prevalence of allergies and the convenience of OTC medications.

Cost Structure

The cost structure for Promethazine VC Plain includes manufacturing costs, distribution expenses, and regulatory compliance costs. Generic manufacturers often have lower costs due to reduced research and development expenses, which can lead to higher profit margins.

Key Takeaways

  • Stable Demand: Promethazine VC Plain continues to see steady demand due to its effectiveness in treating common cold and allergy symptoms.
  • Generic Competition: The availability of generic versions has impacted the revenue trajectory but maintained market share through higher volume sales.
  • Regulatory Compliance: Adherence to FDA regulations is crucial for maintaining market trust and compliance.
  • Seasonal Trends: Demand is influenced by seasonal allergies, leading to fluctuating sales throughout the year.
  • Financial Stability: Despite brand name discontinuation, the market for Promethazine VC Plain is expected to remain stable with moderate growth.

FAQs

What is Promethazine VC Plain used for?

Promethazine VC Plain is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms[4].

Is Promethazine VC Plain available as a brand name?

The brand name "Promethazine VC Plain" has been discontinued in the U.S., but generic versions are still available and approved by the FDA[4].

What are the potential side effects of Promethazine VC Plain?

Potential side effects include dizziness, drowsiness, dry mouth, and serious reactions such as seizures, jaundice, and severe nervous system reactions[4].

How does the pricing of Promethazine VC Plain vary?

Pricing can vary depending on the region, pharmacy, and whether it is a brand name or generic version, ranging from a few dollars to over $10 per unit[2].

What impact does seasonal allergy prevalence have on the demand for Promethazine VC Plain?

Seasonal allergies significantly increase the demand for Promethazine VC Plain, particularly in regions with high pollen counts and allergy prevalence.

Sources

  1. PLOS ONE - Exploratory study on “lean” or “sizzurp” using national survey data and online forum participant input[1].
  2. Wayne HealthCare - 2023 Standard Charges[2].
  3. DrugBank - Promethazine: Uses, Interactions, Mechanism of Action[3].
  4. Drugs.com - Promethazine VC Plain Uses, Side Effects & Warnings[4].
  5. ScienceDirect - Milligram scale enantioresolution of promethazine and its main metabolites[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.